| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absence of latitudinal gradient in oligoclonal bands prevalence in Argentina
|
Negrotto, Laura
|
|
|
46 |
C |
p.
|
artikel
|
| 2 |
Abuse and neglect of people with multiple sclerosis: A survey with the North American Research Committee on Multiple Sclerosis (NARCOMS)
|
Morrison, Elizabeth H.
|
|
|
46 |
C |
p.
|
artikel
|
| 3 |
A case of anti-AQP4 antibody–positive neuromyelitis optica spectrum disorder with MRI-proven lesions in lumbar nerve roots
|
Toru, Shuta
|
|
|
46 |
C |
p.
|
artikel
|
| 4 |
“A case report: Co-occurrence of cerebral amyloid angiopathy and multiple sclerosis”
|
Kobylarek, Dominik
|
|
|
46 |
C |
p.
|
artikel
|
| 5 |
A case report with tuberculous meningitis during fingolimod treatment
|
Köseoğlu, Mesrure
|
|
|
46 |
C |
p.
|
artikel
|
| 6 |
Acute disseminated encephalomyelitis following Tdap vaccination and bacterial meningoencephalitis
|
Niederschweiberer, J.
|
|
|
46 |
C |
p.
|
artikel
|
| 7 |
Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study
|
Carnero Contentti, Edgar
|
|
|
46 |
C |
p.
|
artikel
|
| 8 |
A longitudinal study of symptom botheration in Multiple Sclerosis.
|
Kister, Ilya
|
|
|
46 |
C |
p.
|
artikel
|
| 9 |
An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014–2017
|
Vermersch, Patrick
|
|
|
46 |
C |
p.
|
artikel
|
| 10 |
Anemia and sarcoidosis following treatment with alemtuzumab
|
Love, Brandy
|
|
|
46 |
C |
p.
|
artikel
|
| 11 |
Application of the 2015 neuromyelitis optica spectrum disorders diagnostic criteria in a cohort of Chinese patients
|
He, Mianwang
|
|
|
46 |
C |
p.
|
artikel
|
| 12 |
A Rare Case of Cerebellar Progressive Multifocal Leukoencephalopathy due to Idiopathic CD4 Lymphocytopenia
|
Sutton, Paige
|
|
|
46 |
C |
p.
|
artikel
|
| 13 |
Are fatigue scales the same? A content comparison using the International Classification of Functioning, Disability and Health
|
Alghwiri, Alia A.
|
|
|
46 |
C |
p.
|
artikel
|
| 14 |
Are multiple sclerosis patients and their caregivers more anxious and more committed to following the basic preventive measures during the COVID-19 pandemic?
|
Talaat, Farouk
|
|
|
46 |
C |
p.
|
artikel
|
| 15 |
Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients
|
Mantero, Vittorio
|
|
|
46 |
C |
p.
|
artikel
|
| 16 |
Association between acute disseminated encephalomyelitis and thyroid autoimmunity in children
|
Wang, Yuanyuan
|
|
|
46 |
C |
p.
|
artikel
|
| 17 |
A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS
|
Skorve, Ellen
|
|
|
46 |
C |
p.
|
artikel
|
| 18 |
Atypical clinical and radiological presentation of multiple sclerosis: A case report
|
Ghorpade, Rina
|
|
|
46 |
C |
p.
|
artikel
|
| 19 |
Benefit-harm balance of fingolimod in patients with MS: A modelling study based on FREEDOMS
|
Spanu, Alessandra
|
|
|
46 |
C |
p.
|
artikel
|
| 20 |
Benign SARS-CoV-2 infection in MOG-antibodies associated disorder during tocilizumab treatment
|
Masuccio, Fabio Giuseppe
|
|
|
46 |
C |
p.
|
artikel
|
| 21 |
Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?
|
Maillart, Elisabeth
|
|
|
46 |
C |
p.
|
artikel
|
| 22 |
Biomarkers of inflammation and epithelial barrier function in multiple sclerosis
|
Olsson, A.
|
|
|
46 |
C |
p.
|
artikel
|
| 23 |
Bipolar disorders and deep grey matter in multiple sclerosis: A preliminary quantitative MRI study
|
Lorefice, L.
|
|
|
46 |
C |
p.
|
artikel
|
| 24 |
Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China
|
Cao, Guanmei
|
|
|
46 |
C |
p.
|
artikel
|
| 25 |
Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients
|
Izadi, Morteza
|
|
|
46 |
C |
p.
|
artikel
|
| 26 |
Chronic fatigue and depression due to multiple sclerosis: Immune-inflammatory pathways, tryptophan catabolites and the gut-brain axis as possible shared pathways
|
Ormstad, Heidi
|
|
|
46 |
C |
p.
|
artikel
|
| 27 |
Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder
|
Cai, L.J.
|
|
|
46 |
C |
p.
|
artikel
|
| 28 |
CLINICAL course of acute disseminated encephalomyelitis in adults from Rio de Janeiro: Retrospective study of 23 cases and literature review
|
Guimarães, Marcell Pourbaix Morisson
|
|
|
46 |
C |
p.
|
artikel
|
| 29 |
CNS demyelination during tofacitinib therapy: First report
|
Massoud, Fathi
|
|
|
46 |
C |
p.
|
artikel
|
| 30 |
Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate
|
Cherian, Ajith
|
|
|
46 |
C |
p.
|
artikel
|
| 31 |
Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients
|
Abbatemarco, Justin R.
|
|
|
46 |
C |
p.
|
artikel
|
| 32 |
Complete spinal cord involvement from neuromyelitis optica spectrum disorder in an adult female with anti-synthetase syndrome
|
Wang, Zi-Yi
|
|
|
46 |
C |
p.
|
artikel
|
| 33 |
Could Sars-Cov2 affect MS progression?
|
Di Stadio, Arianna
|
|
|
46 |
C |
p.
|
artikel
|
| 34 |
Could the performance of oral glucose tolerance test contribute to the brain health-focused care in multiple sclerosis?
|
Maric, Gorica
|
|
|
46 |
C |
p.
|
artikel
|
| 35 |
COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID
|
Fiorella, Celsi
|
|
|
46 |
C |
p.
|
artikel
|
| 36 |
Demographic and clinical characterization of multiple sclerosis in Mexico: The REMEMBer study
|
Bertado-Cortés, Brenda
|
|
|
46 |
C |
p.
|
artikel
|
| 37 |
Depression in multiple sclerosis patients associated with risk variant near NEGR1
|
Brugger, Steven W.
|
|
|
46 |
C |
p.
|
artikel
|
| 38 |
Dermatographism associated with ocrelizumab
|
Raynowska, Jenelle
|
|
|
46 |
C |
p.
|
artikel
|
| 39 |
Determinants of unemployment in multiple sclerosis (MS): The role of disease, person-specific factors, and engagement in positive health-related behaviors
|
Strober, Dr. Lauren
|
|
|
46 |
C |
p.
|
artikel
|
| 40 |
Differential diagnosis in acute inflammatory myelitis
|
Marrodan, M.
|
|
|
46 |
C |
p.
|
artikel
|
| 41 |
Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study
|
Villaverde-González, Ramón
|
|
|
46 |
C |
p.
|
artikel
|
| 42 |
Discordant disability data in multiple sclerosis phase 3 studies among sphingosine-1- receptor modulator drugs
|
Avasarala, Jagannadha
|
|
|
46 |
C |
p.
|
artikel
|
| 43 |
Distinguishing physiological versus pathological serum NfL levels in multiple sclerosis will require serial measurements
|
Smets, I.
|
|
|
46 |
C |
p.
|
artikel
|
| 44 |
Does age at diagnosis influence the use of health services for multiple sclerosis?
|
Mésidor, Miceline
|
|
|
46 |
C |
p.
|
artikel
|
| 45 |
Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis?
|
Galioto, Rachel
|
|
|
46 |
C |
p.
|
artikel
|
| 46 |
Does oral salbutamol improve fatigue in multiple sclerosis? A pilot placebo-controlled study
|
de Almeida, Gustavo M.
|
|
|
46 |
C |
p.
|
artikel
|
| 47 |
Effect size – one size doesn't fit all
|
Cutter, Gary
|
|
|
46 |
C |
p.
|
artikel
|
| 48 |
Effects of 12-week inspiratory muscle training with low resistance in patients with multiple sclerosis: A non-randomised, double-blind, controlled trial
|
Martin-Sanchez, Carlos
|
|
|
46 |
C |
p.
|
artikel
|
| 49 |
Efficacy and safety of azathioprine for neuromyelitis optica spectrum disorders: A meta-analysis of real-world studies
|
Luo, Daohuang
|
|
|
46 |
C |
p.
|
artikel
|
| 50 |
Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity
|
Yang, Meng-Ge
|
|
|
46 |
C |
p.
|
artikel
|
| 51 |
Employment status of people with multiple sclerosis in relation to 10-year changes in functioning and perceived impact of the disease
|
Conradsson, David Moulaee
|
|
|
46 |
C |
p.
|
artikel
|
| 52 |
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia
|
Seery, Nabil
|
|
|
46 |
C |
p.
|
artikel
|
| 53 |
Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity.
|
Sammaraiee, Y.
|
|
|
46 |
C |
p.
|
artikel
|
| 54 |
Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis
|
Sahraian, Mohammad Ali
|
|
|
46 |
C |
p.
|
artikel
|
| 55 |
Evolving relationship between respiratory functions & impairment in sleep and cognition in patients with multiple sclerosis
|
Hashim, Noha A.
|
|
|
46 |
C |
p.
|
artikel
|
| 56 |
Experimental mouse model of NMOSD produced by facilitated brain delivery of NMO-IgG by microbubble-enhanced low-frequency ultrasound in experimental allergic encephalomyelitis mice
|
Luo, Jiaying
|
|
|
46 |
C |
p.
|
artikel
|
| 57 |
Exploring the performance of outcome measures in MS for predicting cognitive and clinical progression in the following years
|
Damasceno, Alfredo
|
|
|
46 |
C |
p.
|
artikel
|
| 58 |
Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets
|
Jack, Dominic
|
|
|
46 |
C |
p.
|
artikel
|
| 59 |
Feasibility of improving dietary quality using a telehealth lifestyle intervention for adults with multiple sclerosis
|
Wingo, Brooks C.
|
|
|
46 |
C |
p.
|
artikel
|
| 60 |
Fibrinogen: A potential biomarker for predicting disease severity in multiple sclerosis.
|
Ahmad, Usman
|
|
|
46 |
C |
p.
|
artikel
|
| 61 |
Frequency and etiology of acute transverse myelitis in Southern Finland
|
Smith, Emma
|
|
|
46 |
C |
p.
|
artikel
|
| 62 |
High effector-memory CD8+ T-cell levels correlate with high PML risk in natalizumab-treated patients
|
Beldi-Ferchiou, Asma
|
|
|
46 |
C |
p.
|
artikel
|
| 63 |
How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms
|
Nikbakht, Farnaz
|
|
|
46 |
C |
p.
|
artikel
|
| 64 |
How personality traits affect functional outcomes in patients with multiple sclerosis: A scoping review on a poorly understood topic
|
Maggio, Maria Grazia
|
|
|
46 |
C |
p.
|
artikel
|
| 65 |
Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study
|
Vogel, Andre C.
|
|
|
46 |
C |
p.
|
artikel
|
| 66 |
Impaired central drive to plantarflexors and minimal ankle proprioceptive deficit in people with multiple sclerosis
|
Djajadikarta, Zoë J
|
|
|
46 |
C |
p.
|
artikel
|
| 67 |
Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study
|
Kalron, Alon
|
|
|
46 |
C |
p.
|
artikel
|
| 68 |
Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study
|
Blinkenberg, M.
|
|
|
46 |
C |
p.
|
artikel
|
| 69 |
In-depth B cell immunophenotyping to monitor response to anti-CD20 therapy in CNS autoimmunity
|
Su, Elaine
|
|
|
46 |
C |
p.
|
artikel
|
| 70 |
Inflammatory colitis associated with Teriflunomide
|
Esfahani, Neda Zarghami
|
|
|
46 |
C |
p.
|
artikel
|
| 71 |
Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration
|
Ellenberger, David
|
|
|
46 |
C |
p.
|
artikel
|
| 72 |
Is neuromyelitis optica without AQP4-IgG a T-cell mediated disease? insights from checkpoint inhibitor immune-related adverse events
|
Nasralla, Salam
|
|
|
46 |
C |
p.
|
artikel
|
| 73 |
Late onset multiple sclerosis is associated with more severe ventricle expansion
|
Jakimovski, Dejan
|
|
|
46 |
C |
p.
|
artikel
|
| 74 |
Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database
|
Houtchens, Maria K.
|
|
|
46 |
C |
p.
|
artikel
|
| 75 |
Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study
|
Horakova, Dana
|
|
|
46 |
C |
p.
|
artikel
|
| 76 |
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study
|
Miller, Aaron E.
|
|
|
46 |
C |
p.
|
artikel
|
| 77 |
Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis
|
Leist, T.
|
|
|
46 |
C |
p.
|
artikel
|
| 78 |
Lymphomatosis cerebri masquerading as the Marburg variant of multiple sclerosis
|
AlOhaly, Nasser
|
|
|
46 |
C |
p.
|
artikel
|
| 79 |
Magnetic resonance imaging at baseline and follow-up to differentiate between pediatric monophasic acquired CNS demyelination and MS
|
Boesen, Magnus Spangsberg
|
|
|
46 |
C |
p.
|
artikel
|
| 80 |
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience
|
Zanghì, Aurora
|
|
|
46 |
C |
p.
|
artikel
|
| 81 |
MOG antibody-related disease with recurrent optic neuritis and sensory polyradiculoneuropathy: A case report
|
Shima, Tomoaki
|
|
|
46 |
C |
p.
|
artikel
|
| 82 |
Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis with considerable white blood cell elevation in cerebrospinal fluid
|
Miller, Corey J.
|
|
|
46 |
C |
p.
|
artikel
|
| 83 |
Neuromyelitis optica spectrum disorder after presumed coronavirus (COVID-19) infection: A case report
|
de Ruijter, Naomi S.
|
|
|
46 |
C |
p.
|
artikel
|
| 84 |
Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience
|
Huang, Wenjuan
|
|
|
46 |
C |
p.
|
artikel
|
| 85 |
NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS
|
Novakova, L.
|
|
|
46 |
C |
p.
|
artikel
|
| 86 |
Nordic walking for people with relapsing-remittent multiple sclerosis: A case series study.
|
Martínez-Lemos, Iván
|
|
|
46 |
C |
p.
|
artikel
|
| 87 |
Normal antibody response after COVID-19 during treatment with cladribine
|
Celius, Elisabeth G.
|
|
|
46 |
C |
p.
|
artikel
|
| 88 |
Occurrence of primary progressive multiple sclerosis in a patient with argyria: Causality or coincidence?
|
Seitz, Immanuel P.
|
|
|
46 |
C |
p.
|
artikel
|
| 89 |
Off-label use of tocilizumab in neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases: A case-series
|
Rigal, J.
|
|
|
46 |
C |
p.
|
artikel
|
| 90 |
Paediatric onset of multiple sclerosis: Analysis of chemokine and cytokine levels in the context of the early clinical course
|
Nohejlova, H.
|
|
|
46 |
C |
p.
|
artikel
|
| 91 |
Paroxysmal symptoms in neuromyelitis optica spectrum disorder: Results from an online patient survey
|
Lotan, Itay
|
|
|
46 |
C |
p.
|
artikel
|
| 92 |
Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosis
|
Manzano, A.
|
|
|
46 |
C |
p.
|
artikel
|
| 93 |
Pharmacotherapy in multiple sclerosis-induced cognitive impairment: A systematic review and meta-analysis
|
Motavalli, Ali
|
|
|
46 |
C |
p.
|
artikel
|
| 94 |
Prediction of long-term disability in Chinese patients with multiple sclerosis: A prospective cohort study
|
Zhang, Yao
|
|
|
46 |
C |
p.
|
artikel
|
| 95 |
Prevalence And Impact Of Myofascial Pain Syndrome In Relapsing-Remitting Multiple Sclerosis And The Effects Of Local Anesthetic Injections For Short-Term Treatment
|
Tutuncu, Mesude
|
|
|
46 |
C |
p.
|
artikel
|
| 96 |
Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes
|
Ciampi, Ethel
|
|
|
46 |
C |
p.
|
artikel
|
| 97 |
Prognostic value of odor identification impairment in multiple sclerosis: 10-Years follow-up
|
da Silva, Ana Martins
|
|
|
46 |
C |
p.
|
artikel
|
| 98 |
Pseudotumoral lesion as a manifestation of acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome)
|
Arenas, Ruben D.
|
|
|
46 |
C |
p.
|
artikel
|
| 99 |
Rapid transfer of knowledge for multiple sclerosis clinical care during COVID-19: ECHO MS
|
Alschuler, Kevin N.
|
|
|
46 |
C |
p.
|
artikel
|
| 100 |
Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study
|
Tourbah, Ayman
|
|
|
46 |
C |
p.
|
artikel
|
| 101 |
Replication of a Claims-based Algorithm to Estimate Multiple Sclerosis Disease Severity in a Commercially Insured Population
|
Toliver, Joshua
|
|
|
46 |
C |
p.
|
artikel
|
| 102 |
Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment
|
Vosoughi, Amir R.
|
|
|
46 |
C |
p.
|
artikel
|
| 103 |
Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
|
Brod, Staley A.
|
|
|
46 |
C |
p.
|
artikel
|
| 104 |
Risk of relapse in patients with neuromyelitis optica spectrum disorder: Recognition and preventive strategy
|
Ma, Xiaoyu
|
|
|
46 |
C |
p.
|
artikel
|
| 105 |
Safety of dimethyl fumarate for multiple sclerosis: A systematic review and meta-analysis
|
Liang, Geoffrey
|
|
|
46 |
C |
p.
|
artikel
|
| 106 |
Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosis
|
Vollmer, Timothy L.
|
|
|
46 |
C |
p.
|
artikel
|
| 107 |
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis
|
Hartung, H-P
|
|
|
46 |
C |
p.
|
artikel
|
| 108 |
Smartphone based behavioral therapy for pain in multiple sclerosis (MS) patients: A feasibility acceptability randomized controlled study for the treatment of comorbid migraine and ms pain
|
Minen, Mia T.
|
|
|
46 |
C |
p.
|
artikel
|
| 109 |
Smell as a clinical-marker for functional limitations in multiple sclerosis: A pilot study
|
Goverover, Yael
|
|
|
46 |
C |
p.
|
artikel
|
| 110 |
Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study
|
Rafiee, Farnaz
|
|
|
46 |
C |
p.
|
artikel
|
| 111 |
Systemic erythematous lupus after treatment of multiple sclerosis with alemtuzumab
|
Adamec, Ivan
|
|
|
46 |
C |
p.
|
artikel
|
| 112 |
Tenofovir as a treatment option for multiple sclerosis
|
Torkildsen, Øivind
|
|
|
46 |
C |
p.
|
artikel
|
| 113 |
Teriflunomide as precipitating factor of renal failure in a patient with relapsing-remitting multiple sclerosis and focal segmental glomerulosclerosis.
|
Dattola, Vincenzo
|
|
|
46 |
C |
p.
|
artikel
|
| 114 |
The current status and challenges in multiple sclerosis management in the Philippines
|
Ignacio, Katrina Hannah D.
|
|
|
46 |
C |
p.
|
artikel
|
| 115 |
The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis
|
Hartung, Daniel M.
|
|
|
46 |
C |
p.
|
artikel
|
| 116 |
The Incidence of Transverse Sinus Stenosis in Multiple Sclerosis: Further Evidence of Pulse Wave Encephalopathy
|
Bateman, Grant Alexander
|
|
|
46 |
C |
p.
|
artikel
|
| 117 |
The patients’ perspective on the perceived difficulties of dual-tasking: development and validation of the Dual-task Impact on Daily-living Activities Questionnaire (DIDA-Q)
|
Pedullà, L.
|
|
|
46 |
C |
p.
|
artikel
|
| 118 |
The relationship between dimensions of mental health and alexithymia in multiple sclerosis patients
|
Christopoulos, Anna L.
|
|
|
46 |
C |
p.
|
artikel
|
| 119 |
The right therapeutic method of ozone therapy used to treat multiple sclerosis patients
|
Travagli, Valter
|
|
|
46 |
C |
p.
|
artikel
|
| 120 |
The transitional phase of multiple sclerosis: The concept of PANGAEA 2.0 evolution study
|
Inojosa, Hernan
|
|
|
46 |
C |
p.
|
artikel
|
| 121 |
The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years
|
Friedova, Lucie
|
|
|
46 |
C |
p.
|
artikel
|
| 122 |
Tired of not knowing what that fatigue score means? Normative data of the Modified Fatigue Impact Scale (MFIS)
|
Strober, L.B.
|
|
|
46 |
C |
p.
|
artikel
|
| 123 |
Two cases of NMOSD with MRI findings mimicking CADASIL
|
Maeda, Kentaro
|
|
|
46 |
C |
p.
|
artikel
|
| 124 |
Urinary tract infection in patients with multiple sclerosis: An overview
|
Medeiros Junior, Washigton Luiz Gomes de
|
|
|
46 |
C |
p.
|
artikel
|
| 125 |
Utilization of video oculography to quantify oculomotor dysfunction in anti-DPPX encephalitis: A case study
|
Blackburn, Kyle
|
|
|
46 |
C |
p.
|
artikel
|
| 126 |
Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders
|
Asseyer, Susanna
|
|
|
46 |
C |
p.
|
artikel
|
| 127 |
Why should Neurologists get involved in family planning?
|
Lechner-Scott, J.
|
|
|
46 |
C |
p.
|
artikel
|
| 128 |
Working ability in individuals with different disease courses of multiple sclerosis: Factors beyond physical impairment
|
Renner, Alina
|
|
|
46 |
C |
p.
|
artikel
|
| 129 |
Would it be recommended treating multiple sclerosis relapses with high dose oral instead intravenous steroids during the COVID-19 pandemic? Yes
|
Segamarchi, Constanza
|
|
|
46 |
C |
p.
|
artikel
|
Tijdschrift beschrijving